Jesus, Ozempic and the weight loss drugs "revolution" are all what the Economist seems to talk about these days. For the past week it's literally the only thing they have been focusing on, world economy be damned.
By "these days" do you mean "this week's issue"? Last week's cover was literally of a stack of US bills blasting into space to represent the strong US economy. I didn't find the GLP-1 topic interesting at first, but it was worth a read and according to quick scan of the app front page, only 4 of the 38 articles offered.
I just looked at Economist's landing page and less than 5% of it was centered around Ozempic and related drugs.